Thyroglobulin type-I-like domains in invariant chain fusion proteins mediate resistance to cathepsin L digestion
10.1074/jbc.M110.186684 6 ChanK.HanX.-D.KanY
Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes
The agency has distinguished between mass-marketed compounded products and patient-specific compounding performed under Section 503A of the FD&C Act, which may remain permissible in narrow circumstances
Svegliati-Baroni G, Ridolfi F, Di Sario A, Casini A, Marucci L, Gaggiotti G, Orlandoni P, Macarri G, Perego L, Benedetti A, Folli F
Aesthetic Treatments for Facial Volume Loss To address Ozempic Face, Dr